Bos Jasper
SEC insider (Form 3/4/5 filer). CIK 0001897789. Director at Braveheart Bio, Inc. (BRVE) and 1 other issuer. 2 reported Form 4/5 transactions since Sep 2024; latest on Aug 5, 2026. Located in SAN FRANCISCO, CA.
Companies Bos Jasper has filed insider reports for
- Braveheart Bio, Inc. (BRVE): Director
- enGene Holdings Inc. (ENGN): Director
Bos Jasper
CIK: 0001897789
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
